Home
Regional Biotech for Global Benefit
England's Northwest is one of the UK's top three
biomedical clusters, which includes the biotechnology,
pharmaceuticals and healthcare industries. This is based on a
major global pharmaceutical presence, a rapidly expanding
biotechnology community, many healthcare companies and
internationally renowned academic and clinical research strengths.
England's Northwest has been recognised as a member of the
'European Super League' of biotech clusters by Strategem,
and in the top 50 in the world by Boston Consulting.
In 2007 the Financial Times described the Northwest as a genuine
rival to 'Overheated London' and one of the most vibrant
and dynamic parts of the UK.
The region has some 200 biomedical companies including seven multinational pharmaceutical companies, employing 20,000 people and it is the highest exporter of pharmaceuticals in the UK (£3.4 billion). The Northwest is home to AstraZeneca's largest R&D facility; the UK's largest University (Manchester) with 50% of its research effort dedicated to life science and medicine; Europe's single largest in-market biomanufacturing community and the National Biomanufacturing Centre in Merseyside; UK Biobank, the largest of its kind in the world; the oldest School of Tropical Medicine in the world and Europe's first dedicated campus based bioincubator.
Our aim is to:
- Provide a fully integrated bio/pharmaceutical company support structure for the region.
- Ensure the continued growth and development of the biotechnology community based on excellence.
- Be fully recognised within Europe's top 10 biotechnology locations.
- Contribute to international biotechnology particularly through the Northwest's major strengths and capabilities including: tissue engineering and regenerative medicine; biohealth informatics; bio/pharmaceutical manufacture; infectious diseases and vaccine development; cancer; neurosciences, clinical genetics; trials infrastructure and molecular and medical imaging.
The cluster is the people, the organisations and the companies within it. We have some great people, a tremendous 'can do' attitude and a real desire to succeed.
